Michael D. : Meet the Master-Hands of Medicine – OncoDaily
Michael D. : Meet the Master-Hands of Medicine / cancer, cancer care, Cancer research, CRISPR, gene therapy, Haydar Frangoul, Michael D., New England Journal
Michael D. : Meet the Master-Hands of Medicine / cancer, cancer care, Cancer research, CRISPR, gene therapy, Haydar Frangoul, Michael D., New England Journal
Triple-negative breast cancer (TNBC) is a heterogeneous disease and we have previously shown that rapid relapse of TNBC is associated with distinct sociodemographic features. We…
Being a whistleblower is a required part of our duty as doctors – so why are we treated so terribly for doing it?
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the…
View this file, and add comments too.
Schizophrenia poses significant societal challenges, including interpersonal tension, an increased risk of suicide, and soaring medical costs. Althoug…
Nurses ‘sacrifice their health and wellbeing’ to help plug gaps in rotas, Royal College of Nurses says
The repositioning of shelved assets for pediatric applications presents a promising avenue for advancing therapies for childhood tumors. Tovorafenib, originally intended for adult melanoma, received…
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the…
PURPOSE Targeted Agent and Profiling Utilization Registry is a phase II basket trial evaluating the antitumor activity of commercially available targeted agents in patients with…
Standard treatment with neoadjuvant nivolumab plus chemotherapy significantly improves outcomes in patients with resectable non–small-cell lung cancer (NSCLC). Perioperative treatment (i.e., neoadj…